ANNOVIS BIO INC
ANVS·03615A108·US·Common Stock·Healthcare - Biotechnology-13D/G
ANVS (ANNOVIS BIO INC) is held by 27 institutional investors as of Q1 2026. Largest holders: MARSHALL WACE, LLP ($2.6M), VANGUARD CAPITAL MANAGEMENT LLC ($1.9M), TWO SIGMA INVESTMENTS, LP ($1.4M). Net institutional sentiment: Mixed.
27
Holders
Avg rating(6 Elite)
$9.5M
Total Value
54% (34)
Fund Consensus
14 buying - 12 selling
Who's Trading
InsiderHBHoffman Michael BBuy $1.5MApr 2, 2026
InsiderHBHoffman Michael BBuy $64KDec 8, 2025
InsiderHBHoffman Michael BBuy $130KDec 8, 2025
InsiderHBHoffman Michael BBuy $117KNov 24, 2025
InsiderHBHoffman Michael BBuy $2KNov 24, 2025
InsiderHBHoffman Michael BBuy $35KNov 24, 2025
InsiderHBHoffman Michael BBuy $6KNov 24, 2025
InsiderHBHoffman Michael BBuy $35KNov 21, 2025
InsiderHBHoffman Michael BBuy $35KNov 21, 2025
ActivistCICVI Investments, Inc.4.9%May 12, 2025
13F: Insider & Congress:
Showing 1-20 of 34
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer